Antibody-Drug Conjugates for Breast Cancer | Sara M Tolaney, MD, MPH

Posted on 03/01/2026
25:26 |

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Antibody-Drug Conjugates for Breast Cancer | Faculty Presentation 2: Current and Emerging Role of TROP2-Directed ADCs — Sara M Tolaney, MD, MPH

CME information and select publications